TENS Unit To Decrease Pain After Laminaria Insertion
Completed · Not applicable · Has a placebo group
Conditions studied: Second Trimester Abortion
In brief
The purpose of the study is to learn more about the transcutaneous nerve stimulation (TENS) unit, an over-the-counter option for pain relief that is not a medication. The investigators are hoping to find out if this device decreases pain during and after laminaria placement for patients undergoing both elective and medically indicated second-trimester termination of pregnancy.
Key facts
- Study ID
- NCT06529003
- Run by
- Queen's Medical Center
- People needed
- 36
- Starts
- 2024-08-14
- Expected to finish
- 2025-11-05
- Last updated by the study team
- 2025-12-16
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing laminaria insertion for D\&E procedure
- Age 18 years or older
- Capability and willingness to send and receive SMS messages by phone and complete web-based surveys
- Capability to read and understand directions for using a TENS unit
- Capability to operate a TENS unit according to provided directions
You may not qualify if…
- Inability to complete the informed consent in English
- Exposure to adjunctive pharmacologic cervical preparation (misoprostol or mifepristone) within 48 hours of the D\&E procedure
- Contraindication to ibuprofen or bupivacaine
- Contraindication to TENS, including cardiac pacemakers, epilepsy, bleeding disorders, cancer, and concurrent use near transdermal drug delivery systems
- Previous participation in this trial
- Prior use of TENS unit
Where it is running
- 1380 Lusitana St. Ste 1004 — Honolulu, Hawaii, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.